Kocaeli University Hospital
Kocaeli, Turkey (Türkiye)
NCT Number: NCT05575531
In this study, it was aimed to determine the effect of HRU and HG on patient outcomes in the care process in surgical patients followed according to MEUSS.
The sample of the study, which was conducted as a randomized-controlled clinical trial, consisted of 252 patients who underwent surgical intervention under general anesthesia in a university hospital between 29 July 2022 and 31 October 2022.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Kocaeli, Turkey (Türkiye)
Postoperative patients are at risk of clinical worsening and minimizing this is vital. Nurses play a vital role in the early detection and management of clinical deterioration as they are the group of professionals with the highest patient contact. MEUSS is stated as a simple risk management tool based on physiological parameters that can allow early detection of clinical deterioration and initiation of the relevant intervention, improving the quality of care and patient safety provided to surgical patients.
In this study, with a larger sample, patients will be followed up with MEUSS and a nursing guide for 2 hours in the clinic where they are transferred both after and after ASBU. Our study is a research with the highest sample in this field, in which patients are followed for the longest period of time, and it is thought that MEUSS and nursing guide applications can identify risky patients in the postoperative period and reduce postoperative complications with strict follow-up applied to these patients. The aim of this study; To determine the effect of Nursing Guide Practice (HRU) and Nursing Interventions (HG) on patient outcomes in the care process in surgical patients followed according to MEUSS.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MEWSS and Nursing Guide application will be used for the patients in the experimental group. According to the Nursing Guide application, patients with MEWS above 4 will be monitored every 5 minutes, while those with a score below 4 will be monitored for 10 minutes. will be followed intermittently. Nursing interventions will be made in accordance with the problems experienced by patients with a score above 4.
Time frame: From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour
Length of stay in ASBU (minutes), complications developed in ASBU, intervention time to complications (minutes), and where it was transferred after ASBU (clinical or intensive care unit)
Time frame: From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour
Heart rate (beats per minute), respiratory rate (respiratory rate / min.), systolic blood pressure (mmHg), temperature (centigrade degree -°C), level of consciousness (AVPU) and the score obtained from these measurements show MEWS.
Time frame: From the first 5 minutes when the patient comes to the post-anesthesia care unit to the end of the second hour
Nursing interventions include practices such as oxygen saturation, blood pressure, pulse, respiration, body temperature, alertness, pain monitoring by nurses, positioning and giving medication.
Kocaeli University
Other
The Effect of Modified Early Warning Scoring System and Nursing Guide Practices on Postoperative Patient Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07577349
Clinical Deterioration, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06077851
Clinical Deterioration, Disease Attributes
Copenhagen, NV, Denmark
View Trial DetailsNCT06442488
Clinical Deterioration, Disease Attributes
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06099327
Clinical Deterioration, Disease Attributes
Eindhoven, North Brabant, Netherlands
View Trial Details